<?xml version="1.0" encoding="UTF-8"?>
<p class="p">More than a third of the Worldâ€™s population (about two billion people) lives in malaria-endemic areas. The majority of deaths caused by falciparum malaria occur in sub-Saharan Africa, primarily among children younger than 5 years and pregnant women living in remote rural areas with limited access to health services [
 <xref rid="B11-molecules-16-08273" ref-type="bibr" class="xref">11</xref>]. Nearly all malaria deaths and a large proportion of morbidity are caused by 
 <italic class="italic">Plasmodium falciparum</italic>. In the last decades, resistance to several antimalarial drugs became widely disseminated, while the cost of effective treatments was prohibitive for the majority of the populations in the endemic regions. Thus, rapid development of resistance by 
 <italic class="italic">P. falciparum</italic> to the conventional drugs necessitates search for new antimalarial drugs [
 <xref rid="B11-molecules-16-08273" ref-type="bibr" class="xref">11</xref>].
</p>
